Real-World Studies of Ocriplasmin Show Different Outcomes Than Trials
Researchers reviewed findings from various research to show how patients respond to the therapeutic.
Researchers reviewed findings from various research to show how patients respond to the therapeutic.
Researchers say these characteristics can help identify the condition’s severity.
Investigators compared outcomes of two methods of internal limiting membrane peeling for these patients.
The treatment can help improve central macular thickness and visual acuity for patients with diabetic macular edema.
The multicenter study confirms improvements in acuity and central retinal thickness.
Researchers propose a review of the staging system to better identify disease earlier.
Researchers used data from the VISTA clinical trial to show how imaging technologies can foretell worse leakage and poorer visual acuity.
Microvasculature changes detectable on OCT-A correlate to functional loss.
The therapy “synergistically reduced inflammation, leakage, and neovascularization,” research shows.
Investigators used OCT scans to identify anatomic alterations that precede macular atrophy.